內視鏡逆行性造影(ERCP) 市場規模、佔有率和成長分析：按類型、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

內視鏡逆行性造影（ERCP）市場規模2022年估值為19億美元，在預測期內從2023年的20.9億美元成長到2031年的44.1億美元（預計複合年成長率為9.80%） （2024） -2031）。

微創手術技術的興起增加了對內視鏡逆行性造影（ERCP）手術的需求，為未來幾年產業的強勁成長奠定了基礎。選擇 ERCP 的患者數量不斷增加，主要是因為微創方法的優點，與傳統手術技術相比，這種方法可以實現更快的恢復時間和更少的併發症。此外，美國癌症協會 2023 年 1 月年度報告預測，美國新增約 41,210 例肝癌病例，凸顯了對先進診斷和治療解決方案的迫切需求。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 成功的關鍵因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

內視鏡逆行性造影(ERCP) 市場：依類型

• 市場概況
• 內視鏡
• 內視鏡治療裝置
• 影像系統
• 能源裝置
• 其他

內視鏡逆行性造影(ERCP) 市場：依應用分類

• 市場概況
• 膽管括約肌切開術
• 膽管支架
• 膽管擴張
• 胰管支架置入術
• 胰管擴張
• 胰臟括約肌切開術

內視鏡逆行性造影(ERCP) 市場：依最終用戶分類

• 市場概況
• 醫院/診所
• 門診手術中心

內視鏡逆行性造影(ERCP) 市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Olympus Corporation
• CONMED Corporation
• HOYA Corporation
• Fujifilm Holdings Corporation
• KARL STORZ SE & Co. KG
• Ambu A/S
• Johnson & Johnson
• Boston Scientific Corporation
• Medtronic PLC
• Cook Medical
• B. Braun Melsungen AG.

Endoscopic Retrograde Cholangiopancreatography Market size was valued at USD 1.9 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 4.41 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).

The rise of minimally invasive surgical methods has led to an increased demand for endoscopic retrograde cholangiopancreatography (ERCP) procedures, setting the stage for a robust industry growth in the coming years. The growing number of patients opting for ERCP is primarily driven by the benefits of minimally invasive approaches, which promise quicker recovery times and fewer complications compared to traditional surgical techniques. Additionally, the American Cancer Society's January 2023 annual report projects approximately 41,210 new cases of liver cancer in the United States, underscoring the urgent requirement for advanced diagnostic and therapeutic solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Endoscopic Retrograde Cholangiopancreatography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Endoscopic Retrograde Cholangiopancreatography Market Segmental Analysis

Endoscopic retrograde cholangiopancreatography market is segmented based on product type, application, end user, and region. Based on product type, the market is segmented into endoscopes, endotherapy devices, imaging systems, energy devices, and others. Based on application, the market is segmented into Biliary Sphincterotomy, Biliary Stenting, Biliary Dilatation, Pancreatic Duct Stenting, Pancreatic Duct Dilatation, Pancreatic Sphincterotomy. Based on end user, the market is segmented into hospitals & clinics and ambulatory surgical centers, and others. Based on region, the market is segmented into North America, Europe, APAC, Middle East and Africa, LATAM.

Drivers of the Endoscopic Retrograde Cholangiopancreatography Market

ERCP, short for endoscopic retrograde cholangiopancreatography, is a specialized medical procedure designed for both diagnosing and treating conditions affecting the pancreas, liver, gallbladder, and bile ducts. This diagnostic and therapeutic technique combines luminal endoscopy with fluoroscopy-based imaging, providing a comprehensive approach to addressing pancreatobiliary diseases. The procedure involves using an endoscope-a flexible, elongated, and illuminated tube-alongside X-ray technology. The endoscope is carefully guided through the digestive system to enable direct visualization of the targeted organs and systems. Concurrently, X-ray images are captured to provide detailed information about the pancreas, liver, gallbladder, and bile ducts.

Restraints in the Endoscopic Retrograde Cholangiopancreatography Market

The market's growth is constrained by strict regulatory guidelines imposed by regulatory bodies in various countries, which present challenges for introducing new technologies. Compliance with these regulations requires rigorous testing and adherence to safety and efficacy standards, contributing to a complex and time-consuming approval process for new medical technologies. Despite these regulatory challenges, the market is experiencing some positive impacts. The increase in disposable income, particularly in developing countries, has emerged as a catalyst for market expansion.

Market Trends of the Endoscopic Retrograde Cholangiopancreatography Market

The market is expected to gain substantial momentum from strategic initiatives undertaken by key industry players, such as impactful actions including product launches, mergers, and acquisitions. A notable example is the strategic distribution agreement forged between Olympus and EndoClot Plus in April 2022. EndoClot Plus, a specialist in hemostasis technology, introduced the EndoClot PHS-a nonthermal, nontraumatic method designed for fast and reliable hemostasis in gastrointestinal bleeding. This collaboration highlights the market's commitment to advancing existing solutions in therapeutic endoscopy.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Endoscopic Retrograde Cholangiopancreatography Market by Type

• Market Overview
• Endoscopes
• Endo-therapy Devices
• Imaging Systems
• Energy Devices
• Others

Endoscopic Retrograde Cholangiopancreatography Market by Application

• Market Overview
• Biliary Sphincterotomy
• Biliary Stenting
• Biliary Dilatation
• Pancreatic Duct Stenting
• Pancreatic Duct Dilatation
• Pancreatic Sphincterotomy

Endoscopic Retrograde Cholangiopancreatography Market by End User

• Market Overview
• Hospitals & Clinic
• Ambulatory Surgical Centres

Endoscopic Retrograde Cholangiopancreatography Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Olympus Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CONMED Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HOYA Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KARL STORZ SE & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ambu A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments